Serum trace metal levels in Alzheimer's disease and normal control groups

American Journal of Alzheimer's Disease and other Dementias

Volumn 29, Issue 1, 2014, Pages 76-83

  Park, Jun Hyun ^a   Lee, Dong Woo ^a   Park, Kyung Su ^b   Joung, Hyojee ^c  

^a Inje University College of Medicine   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Alzheimer's disease; cadmium; heavy metal toxicity; lead

Indexed keywords

ARSENIC; CADMIUM; LEAD; MERCURY; TRACE METAL;

AGED; ALZHEIMER DISEASE; ARSENIC BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CADMIUM BLOOD LEVEL; COGNITION; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HUMAN; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MERCURY BLOOD LEVEL; TRACE METAL BLOOD LEVEL; VERBAL MEMORY; VERY ELDERLY; WORD LIST RECALL; WORD LIST RECOGNITION; WORD RECOGNITION;

ALZHEIMER'S DISEASE; CADMIUM; HEAVY METAL TOXICITY; LEAD;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ARSENIC; CADMIUM; CASE-CONTROL STUDIES; COGNITION DISORDERS; EATING; FEMALE; HUMANS; LEAD; MALE; MENTAL RECALL; MERCURY; MIDDLE AGED; RECOGNITION (PSYCHOLOGY); SEVERITY OF ILLNESS INDEX;

EID: 84894494480     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317513506778     Document Type: Article

References (64)

1. Casado A, Encarnación López-Fernández M, Concepción Casado M, de La Torre R. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res. 2008 ; 33 (3). 450-458
2. Delibas N, Ozcankaya R, Altuntas I. Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval. Clin Biochem. 2002 ; 35 (2). 137-141
3. Adlard PA, Bush AI. Metals and Alzheimer's disease. J Alzheimers Dis. 2006 ; 10 (2-3). 145-163
4. Bonda DJ, Lee HG, Blair JA, Zhu X, Perry G, Smith MA. Role of metal dyshomeostasis in Alzheimer's disease. Metallomics. 2011 ; 3 (3). 267-270
5. Hegde ML, Anitha S, Latha KS, et al. First evidence for helical transitions in supercoiled DNA by amyloid beta peptide (1-42) and aluminum: a new insight in understanding Alzheimer's disease. J Mol Neurosci. 2004 ; 22 (1-2). 19-31
6. Dani SU. Arsenic for the fool: an exponential connection. Sci Total Environ. 2010 ; 408 (8). 1842-1846
7. Duce JA, Bush AI. Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics. Prog Neurobiol. 2010 ; 92 (1). 1-18
8. Gharibzadeh S, Hoseini SS. Arsenic exposure may be a risk factor for Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2008 ; 20 (4). 501
9. Haraguchi T, Ishizu H, Takehisa Y, et al. Lead content of brain tissue in diffuse neurofibrillary tangles with calcification (DNTC): the possibility of lead neurotoxicity. NeuroReport. 2001 ; 12 (18). 3887-3890
10. Lam PK, Kritz-Silverstein D, Barrett Connor E, et al. Plasma trace elements and cognitive function in older men and women: the Rancho Bernardo study. J Nutr Health Aging. 2008 ; 12 (1). 22-27
11. McClain CJ, McClain M, Barve S, Boosalis MG. Trace metals and the elderly. Clin Geriatr Med. 2002 ; 18 (4). 801-818
12. Mutter J, Naumann J, Schneider R, Walach H. Mercury and Alzheimer's disease [in German]. Fortschr Neurol Psychiatr. 2007 ; 75 (9). 528-538
13. Atwood CS, Huang X, Moir RD, Tanzi RE, Bush AI. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. Met Ions Biol Syst. 1999 ; 36: 309-364
14. Chowdhury BA, Chandra RK. Biological and health implications of toxic heavy metal and essential trace element interactions. Prog Food Nutr Sci. 1987 ; 11 (1). 55
15. Gong G, O'Bryant SE. The arsenic exposure hypothesis for Alzheimer disease [published online May 13, 2010]. Alzheimer Dis Assoc Disord. 2010 ;:
16. Weuve J, Korrick SA, Weisskopf MA, et al. Cumulative exposure to lead in relation to cognitive function in older women. Environ Health Perspect. 2009 ; 117 (4). 574-580
17. Khalil N, Morrow LA, Needleman H, Talbott EO, Wilson JW, Cauley JA. Association of cumulative lead and neurocognitive function in an occupational cohort. Neuropsychology. 2009 ; 23 (1). 10-19
18. Yun S, Hoyer S. Effects of low-level lead on glycolytic enzymes and pyruvate dehydrogenase of rat brain in vitro: relevance to sporadic Alzheimer's disease?. J Neural Transm. 2000 ; 107 (3). 355-368
19. Patra RC, Swarup D, Senapati SK. Effects of cadmium on lipid peroxides and superoxide dismutase in hepatic, renal and testicular tissue of rats. Vet Hum Toxicol. 1999 ; 41 (2). 65
20. Costa L, Fox D. A selective decrease of cholinergic muscarinic receptors in the visual cortex of adult rats following developmental lead exposure. Brain Res. 1983 ; 276 (2). 259-266
21. Webster WS, Valois AA. The toxic effects of cadmium on the neonatal mouse CNS. J Neuropathol Exp Neurol. 1981 ; 40 (3). 247
22. Gerhardsson L, Lundh T, Londos E, Minthon L. Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer's disease. J Neural Transm. 2011 ; 118 (6). 957-962
23. Mutter J, Curth A, Naumann J, Deth R, Walach H. Does inorganic mercury play a role in Alzheimer's disease? A systematic review and an integrated molecular mechanism. J Alzheimers Dis. 2010 ; 22 (2). 357-374
24. Llobet J, Falco G, Casas C, Teixido A, Domingo J.. Concentrations of arsenic, cadmium, mercury, and lead in common foods and estimated daily intake by children, adolescents, adults, and seniors of Catalonia, Spain. J Agric Food Chem. 2003 ; 51 (3). 838-842
25. Alkorta I, Hernández-Allica J, Becerril J, Amezaga I, Albizu I, Garbisu C. Recent findings on the phytoremediation of soils contaminated with environmentally toxic heavy metals and metalloids such as zinc, cadmium, lead, and arsenic. Rev Environ Sci Biotechnol. 2004 ; 3 (1). 71-90
26. Chigbo FE, Smith RW, Shore FL. Uptake of arsenic, cadmium, lead and mercury from polluted waters by the water hyacinth. Eichornia crassipes Environ Pollut Series A Ecol Biol. 1982 ; 27 (1). 31-36
27. Peraza MA, Ayala-Fierro F, Barber DS, Casarez E, Rael LT. Effects of micronutrients on metal toxicity. Environ Health Perspect. 1998 ; 106 (suppl 1). 203
28. Hwang Y, Park S, Park G, Choi S, Kim M. Total arsenic, mercury, lead, and cadmium contents in edible dried seaweed in Korea. Food Addit Contamin Part B. 2010 ; 3 (1). 7-13
29. Lee HS, Cho YH, Park SO, et al. Dietary exposure of the Korean population to arsenic, cadmium, lead and mercury. J Food Compos Anal. 2006 ; 19 (suppl). S31 - S37
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 ; 34 (7). 939-939
31. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004 ; 256 (3). 240-246
32. Seo EH, Lee DY, Lee JH, et al. Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies. Am J Geriatr Psychiatry. 2010 ; 18 (9). 801-809
33. Dietary Intake and Risk Assessment of Contaminants in Korean Foods. Seoul, Korea: Korea Food and Drug Administration ; 2009
34. Lee JH, Lee KU, Lee DY, et al. Development of the Korean Version of the consortium to establish a registry for Alzheimer's disease assessment packet (CERAD-K). J Gerontol B Psychol Sci Soc Sci. 2002 ; 57 (1). P47 - P53
35. SAS Procedures Guide. Version 8. Cary, NC: SAS Institute ; 1999
36. Schoonjans F Medcalc Statistics for Biomedical Research: Software Manual. Mariakerke, Belgium: Medcalc Statistical Software ; 2003
37. Mantere P, Hanninen H, Hernberg S, Luukkonen R. A prospective follow-up study on psychological effects in workers exposed to low levels of lead. Scand J Work Environ Health. 1984 ; 10 (1). 43-50
38. Schroter C, Schroter H, Huffmann G. Neurologic and psychiatric manifestations of lead poisoning in adults (case report and review of the literature) [in German]. Fortschr Neurol Psychiatr. 1991 ; 59 (10). 413-424
39. Schwartz BS, Caffo B, Stewart WF, et al. Evaluation of cumulative lead dose and longitudinal changes in structural magnetic resonance imaging in former organolead workers. J Occup Environ Med. 2010 ; 52 (4). 407-414
40. Schwartz BS, Stewart W, Bolla K, et al. Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology. 2000 ; 55 (8). 1144-1150
41. Weisskopf MG, Hu H, Mulkern RV, et al. Cognitive deficits and magnetic resonance spectroscopy in adult monozygotic twins with lead poisoning. Environ Health Perspect. 2004 ; 112 (5). 620-625
42. Bleecker ML, Ford DP, Celio MA, Vaughan CG, Lindgren KN. Impact of cognitive reserve on the relationship of lead exposure and neurobehavioral performance. Neurology. 2007 ; 69 (5). 470-476
43. Weisskopf MG, Proctor SP, Wright RO, et al. Cumulative lead exposure and cognitive performance among elderly men. Epidemiology. 2007 ; 18 (1). 59-66
44. Stollery BT, Banks HA, Broadbent DE, Lee WR. Cognitive functioning in lead workers. Br J Ind Med. 1989 ; 46 (10). 698-707
45. Chang W, Chen J, Wei QY, Chen XM. Effects of Brn-3a protein and RNA expression in rat brain following low-level lead exposure during development on spatial learning and memory. Toxicol Lett. 2006 ; 164 (1). 63-70
46. Williamson A, Teo R. Neurobehavioural effects of occupational exposure to lead. Br J Ind Med. 1986 ; 43 (6). 374-380
47. Gordon J, Taylor A, Bennett P. Lead poisoning: case studies. Br J Clin Pharmacol. 2002 ; 53 (5). 451-458
48. Tüzün M, Tüzün D, Salan A, Hekimoglu B.. Lead encephalopathy: CT and MR findings. J Comput Assist Tomogr. 2002 ; 26 (3). 479
49. Koller K, Brown T, Spurgeon A, Levy L. Recent developments in low-level lead exposure and intellectual impairment in children. Environ Health Perspect. 2004 ; 112 (9). 987
50. Sharifi AM, Baniasadi S, Jorjani M, Rahimi F, Bakhshayesh M. Investigation of acute lead poisoning on apoptosis in rat hippocampus in vivo. Neurosci Lett. 2002 ; 329 (1). 45-48
51. Stewart WF, Schwartz BS. Effects of lead on the adult brain: a 15-year exploration. Am J Ind Med. 2007 ; 50 (10). 729-739
52. Struzyńska L, Walski M, Gadamski R, Dabrowska-Bouta B, Rafałowska U. Lead-induced abnormalities in blood-brain barrier permeability in experimental chronic toxicity. Mol Chem Neuropathol. 1997 ; 31 (3). 207-224
53. Hwang KY, Lee BK, Bressler JP, Bolla KI, Stewart WF, Schwartz BS. Protein kinase C activity and the relations between blood lead and neurobehavioral function in lead workers. Environ Health Perspect. 2002 ; 110 (2). 133
54. Salthouse TA. The processing-speed theory of adult age differences in cognition. Psychol Rev. 1996 ; 103 (3). 403
55. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001 ; 58 (12). 1985
56. Vig EK, Hu H.. Lead toxicity in older adults. JAm Geriatr Soc. 2000 ; 48 ((11). 1501
57. Bomboi G, Marchione F, Sepe-Monti M, et al. Correlation between metal ions and clinical findings in subjects affected by Alzheimer's disease. Annali Ist Super Sanita. 2005 ; 41 (2). 205-212
58. Gerhardsson L, Lundh T, Minthon L, Londos E. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 2008 ; 25 (6). 508-515
59. Bocca B, Forte G, Petrucci F, et al. Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita. 2005 ; 41 (2). 197-203
60. Basun H, Lind B, Nordberg M, Nordstrom M, Bjorksten KS, Winblad B. Cadmium in blood in Alzheimer's disease and non-demented subjects: results from a population-based study. Biometals. 1994 ; 7 (2). 130-134
61. Basun H, Forssell LG, Wetterberg L, Winblad B. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J Neural Transm Park Dis Dement Sect. 1991 ; 3 (4). 231-258
62. Andersson H, Petersson-Grawe K, Lindqvist E, Luthman J, Oskarsson A, Olson L. Low-level cadmium exposure of lactating rats causes alterations in brain serotonin levels in the offspring. Neurotoxicol Teratol. 1997 ; 19 (2). 105-115
63. Jin T, Lu J, Nordberg M. Toxicokinetics and biochemistry of cadmium with special emphasis on the role of metallothionein. Neurotoxicology. 1998 ; 19 (4-5). 529-535
64. Tjälve H, Henriksson J, Tallkvist J, Larsson BS, Lindquist NG. Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacol Toxicol. 2009 ; 79 (6). 347-356